Richard Sullivan is Professor, Cancer Policy & Global Health at Kings College London and founding director of the new Kings Institute of Cancer Policy. Richard is an executive member of the Kings Health Partners Cancer Centre and is Visiting Professor at the Faculty of Medicine, Universidad Catolica, Chile. Richard also serves on the King’s Centre for Global Health where he co-leads the conflict & health program and global cancer.

 

Richard qualified in medicine at St. Marys Hospital, London. Following training in surgery he completed his PhD in cell signalling at University College London. After a period in the pharmaceutical industry he then spent nearly a decade with one of the worlds largest cancer research NGO’s Cancer Research UK as their clinical director. In 2008 Richard moved to the London School of Economics were he worked on complex healthcare systems within the health, society and population programme focusing on conflict and post conflict public health settings in the Balkans, Africa and the Middle East, before joining Kings College London in 2010.  

 

Richard works with a wide variety of global health and international organisations, and is past UK Director of the Council for Emerging National Security Affairs (CENSA) a national security think-tank where he specialised in counter-proliferation and the security implications of global health.  Richard’s research programmes focus on two areas: global cancer policy and conflict & health focusing on health systems in high-risk, conflict areas focusing on DR Congo, Afghanistan & Libya. He leads a number of programs including studies of the basic package of health services in Afghanistan, armed violence reduction and public health and the relationship between security and global health. In global cancer public policy Richard has led a number of major Lancet Commissions - Affordability of cancer in high-income countries, global childhood cancer care, cancer care in Latin America and most recently a major series on Health and Cancer in India. Richard is currently a Lancet Commissioner for Global Surgery leading cancer surgery, and a lead for civilian-military co-operation and global health programme.